Literature DB >> 23072424

Incidence of hepatitis C virus infection in patients on hemodialysis: a systematic review and meta-analysis.

Yingying Su1, Jessie L Norris, Chunpeng Zang, Zhihang Peng, Ning Wang.   

Abstract

Hepatitis C virus infection is a perennial concern for hemodialysis units because the prevalence of hepatitis C is significantly higher there than in the general population. Through a systematic review and meta-analysis, we aim to assess the incidence rate of hepatitis C virus infection in hemodialysis units and explore its potential risk factors. Five electronic databases were used to search articles from 1990 to 2012, including PubMed, Embase, China National Knowledge Infrastructure, Chinese Biomedical Literature Database, and Wanfang. A random-effects analysis was used to estimate the overall incidence rate of hepatitis C virus infection. A subgroup analysis and meta-regression analysis were conducted to explore factors associated with heterogeneity between studies. Twenty-two eligible articles were found, including 23 incidence rate estimates. The overall incidence rate of hepatitis C virus infection was 1.47 per 100 patient-years (95% confidence interval [CI] 1.14 to 1.80). In the subgroup analysis, the pooled incidence rate was 4.44 (CI 2.65, 6.23) per 100 patient-years in the developing world and 0.99 (CI 0.66, 1.29) per 100 patient-years in the developed world. [Correction added on 2 November 2012, after first online publication: Pooled incidence rate in the developed world has been changed.] In addition, in hemodialysis units with higher prevalence, the incidence rate of hepatitis C virus infection also tended to be higher. Meta-regression analysis showed that the country's development level and initial HCV prevalence combined could explain 67.91% of the observed heterogeneity. The incidence rate of hepatitis C virus infection among patients on hemodialysis was significantly high. Efforts should be taken to control hepatitis C virus infection in hemodialysis units, especially in developing countries.
© 2012 The Authors. Hemodialysis International © 2012 International Society for Hemodialysis.

Entities:  

Keywords:  HCV; Hepatitis C; epidemiology; hemodialysis; nosocomial infection

Mesh:

Year:  2012        PMID: 23072424     DOI: 10.1111/j.1542-4758.2012.00761.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  11 in total

1.  KDIGO 2018 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2018-09-19

Review 2.  Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.

Authors:  Soheil Ashkani-Esfahani; Seyed Moayed Alavian; Mohammad Salehi-Marzijarani
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

3.  Cidan inhibits liver cancer cell growth by reducing COX-2 and VEGF expression and cell cycle arrest.

Authors:  Nan Li; Donghai Zheng; Jie Xue; Weixing Guo; Jie Shi; Juxian Sun; Chongde Lu; Weida Zheng; Mengchao Wu; Shuqun Cheng
Journal:  Exp Ther Med       Date:  2015-03-13       Impact factor: 2.447

Review 4.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Roberto J Carvalho-Filho; Ana Cristina C A Feldner; Antonio Eduardo B Silva; Maria Lucia G Ferraz
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 5.  Health care-associated hepatitis C virus infection.

Authors:  Bruno Pozzetto; Meriam Memmi; Olivier Garraud; Xavier Roblin; Philippe Berthelot
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

6.  Global prevalence of occult hepatitis C virus: A systematic review and meta-analysis.

Authors:  Donatien Serge Mbaga; Sebastien Kenmoe; Jacky Njiki Bikoï; Guy Roussel Takuissu; Marie Amougou-Atsama; Etienne Atenguena Okobalemba; Jean Thierry Ebogo-Belobo; Arnol Bowo-Ngandji; Martin Gael Oyono; Jeannette Nina Magoudjou-Pekam; Ginette Irma Kame-Ngasse; Alex Durand Nka; Alfloditte Flore Feudjio; Cromwel Zemnou-Tepap; Elie Adamou Velhima; Juliette Laure Ndzie Ondigui; Rachel Audrey Nayang-Mundo; Sabine Aimee Touangnou-Chamda; Yrene Kamtchueng Takeu; Jean Bosco Taya-Fokou; Chris Andre Mbongue Mikangue; Raoul Kenfack-Momo; Cyprien Kengne-Ndé; Carole Stephanie Sake; Seraphine Nkie Esemu; Richard Njouom; Lucy Ndip; Sara Honorine Riwom Essama
Journal:  World J Methodol       Date:  2022-05-20

7.  Hepatitis C in Canada and the importance of risk-based screening.

Authors:  S Ha; S Totten; L Pogany; J Wu; M Gale-Rowe
Journal:  Can Commun Dis Rep       Date:  2016-03-03

8.  Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran.

Authors:  Ali Kargar Kheirabad; Fahime Bahri; Mohammad Kargar; Iman Ghasemzadeh
Journal:  Hepat Mon       Date:  2016-08-13       Impact factor: 0.660

9.  Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period.

Authors:  Andrés Marco; Carlos Gallego; Joan A Caylà
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

10.  Epidemiological Aspects of Hepatitis B and C and Human Immunodeficiency Viruses Among Hemodialysis Patients in Mazandaran Province, Iran.

Authors:  Mohammad Reza Hasanjani Roushan; Safa Farokhtabar; Masomeh Bayani; Sepideh Siadati
Journal:  Nephrourol Mon       Date:  2016-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.